{"schema_version":"1","generated_at":"2026-11-02T21:34:12.349Z","data_as_of":null,"url":"https://www.findmykol.com/kol/frank-basile","json_url":"https://www.findmykol.com/kol/frank-basile/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"frank-basile","name":"Frank Basile","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Schrodinger","institution_url":"https://www.findmykol.com/institution/schrodinger","city":"Hyannis","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1225015340","openalex":"A5103573052"},"summary":"Frank Basile is an Oncology physician affiliated with Schrodinger. OpenAlex indexes 26 publications with 387 citations (h-index 9); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":26,"cited_by_count":387,"h_index":9,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05544019","title":"Study of SGR-1505 in Mature B-Cell Neoplasms","phase":"PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"Schrödinger, Inc.","source_url":"https://clinicaltrials.gov/study/NCT05544019","trial_url":"https://www.findmykol.com/trial/NCT05544019"},{"nct":"NCT01468246","title":"The Young Women's Breast Cancer Study","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"Dana-Farber Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT01468246","trial_url":"https://www.findmykol.com/trial/NCT01468246"}],"source":"trials"},"publications":{"total":29,"shown":5,"withheld":24,"matched_by":"OpenAlex author record","recent":[{"title":"A Phase 1 Dose‐Escalation, Food Effect, and Drug–Drug Interaction Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MALT1 Inhibitor, SGR‐1505, in Healthy Volunteers","year":2026,"journal":"Clinical Pharmacology in Drug Development","source_url":"https://doi.org/10.1002/cpdd.70008","status":"verified"},{"title":"A Phase 1 Dose‐Escalation, Food Effect, and Drug–Drug Interaction Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MALT1 Inhibitor, SGR‐1505, in Healthy Volunteers","year":2026,"journal":"UNC Libraries","source_url":"https://doi.org/10.17615/gn28-gr27","status":"verified"},{"title":"SGR-1505, a potent and selective MALT1 inhibitor with preliminary efficacy in BTKi exposed Waldenström macroglobulinemia (WM) and “double-exposed” CLL/SLL","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-3603","status":"verified"},{"title":"Phase 1/2 trial of the HPK1 inhibitor NDI-101150 as monotherapy and in combination with pembrolizumab: Clinical update.","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.3083","status":"verified"},{"title":"Abstract 2652: NDI-101150 is a potent and highly selective HPK1 inhibitor that both synergizes with and differentiates from anti-PD1 immune checkpoint blockade","year":2024,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.am2024-2652","status":"verified"}],"source":"works"},"contact":{"address_1":"27 PARK ST","city":"Hyannis","state":"MA","zip":"026015230","phone":"508-862-7575","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1225015340","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":24}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2012-11-20","collected_at":"2026-11-02T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"}},"methodology_url":"https://www.findmykol.com/about#methodology"}